BSE filing, NSE: COFORGE. Summary written from the filing by ALFA Finder's alert engine.
Coforge Ltd: key numbers
- Share price
- ₹1,961.90
- Market cap
- ₹86,920 Cr
- Revenue (annual)
- ₹16,403 Cr
- Net profit (annual)
- ₹1,556 Cr
- P/E (TTM)
- 44.1×Sector 23.0×
- Promoter holding
- 0.00%+0.00% QoQ
- FII holding
- 24.75%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Coforge Ltd
All →Coforge Partnership
Coforge announces a community partnership with Chippenham RFC in UK to support rugby, cricket, and local community development. No financial commitment is disclosed in the announcement.
Coforge Business Update
Coforge named a Leader in Everest Group's QE Services PEAK Matrix 2026. The recognition validates its AI-native quality engineering capabilities.
Coforge Earnings Call Transcript: Key Takeaways
Coforge delivered record order intake exceeding $1 billion, led by significant AI embedding and a successful Encore integration.
Coforge Board Meeting Outcome
Coforge Limited's board approved appointment of Price Waterhouse Chartered Accountants LLP as statutory auditor for a 60-month term effective 1 April 2027. The filing is an auditor appointment disclosure under Change in Management.
- Execution
- 60 months from 01-04-2027
Coforge Merger & Restructuring
Coforge's Board noted the completed voluntary liquidation and dissolution of a step-down Italian subsidiary, Digital Mobile Innovations Italy S.R.L. No financial details are disclosed.
Coforge Results Update
Coforge's press release reports quarterly revenue up 53.6% YoY and raises FY27 EBIT margin guidance to 16%. Eight large deals signed this quarter highlight strong momentum.
Other other announcement announcements
All →eMudhra Other Announcement
eMudhra Ltd disclosed that SES ESG revised its ESG score from 68.0 to 64.9 in its ESG Report 2026. The company states it did not engage SES ESG, and the revision relates to its certificate business.
Aarti Pharmalabs Other Announcement
Aarti Pharmalabs has intimated under Regulation 46 that it revamped its website at the existing URL to improve design and accessibility. The notice has no financial or business substance.
Sagarsoft (India) Other Announcement
Sagarsoft (India) filed its Regulation 32 fund utilisation statement for its 2021 preferential issue. No deviation was reported and the full Rs.5.08 Crore was used.
Sadhana Nitro Chem Other Announcement
Sadhana Nitro Chem reported no deviation in use of its preferential issue proceeds for the quarter ended September 2026. The Audit Committee reviewed the statement.
Shriram Asset Management Company Other Announcement
Shriram AMC filed ICRA's quarterly monitoring agency report on preferential issue proceeds. Utilisation is in line with the offer objects, with no deviation reported.
Jhandewalas Foods Other Announcement
Jhandewalas Foods filed its quarterly shareholding pattern for the period ended September 30, 2026. The filing records holdings by category and contains no transaction or money event.